Transgene Biotek informs about standalone financial results

13 Nov 2015 Evaluate

Transgene Biotek has informed about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

6.77 0.22 (3.36%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 344.50
Apollo Hospital Ent. 5837.15
Max Healthcare Inst 810.00
Narayana Hrudayalay 1260.00
Global Health 1410.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.